Phase 1 single-center, dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for adult patients with recurrent malignant glioma.

被引：1
|
作者：
Randazzo, Dina
Desjardins, Annick
Chandramohan, Vidyalakshmi
Sampson, John H.
Peters, Katherine B.
Vlahovic, Gordana
Threatt, Stevie
Herndon, James Emmett
Boulton, Susan
Lally-Goss, Denise
Healy, Patrick
Lipp, Eric S.
Friedman, Allan H.
Bigner, Dare D.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e13532
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13532
引用
收藏
页数：5
相关论文
共 17 条
  • [1] PHASE I DOSE ESCALATION STUDY OF D2C7-IT ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG)
    Desjardins, Annick
    Randazzo, Dina
    Chandramohan, Vidya
    Sampson, John
    Peters, Katherine
    Vlahovic, Gordana
    Threatt, Stevie
    Herndon, James
    Boulton, Susan
    Lally-Goss, Denise
    Healy, Patrick
    Lipp, Eric
    Friedman, Allan
    Friedman, Henry
    Bigner, Darell
    NEURO-ONCOLOGY, 2016, 18 : 21 - 22
  • [2] DOSE ESCALATION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG)
    Desjardins, Annick
    Randazzo, Dina
    Chandramohan, Vidya
    Peters, Katherine
    Johnson, Margaret
    Thomas, Leslie
    Threatt, Stevie
    Bullock, Chevelle
    Herndon, James
    Boulton, Susan
    Healy, Patrick
    Lipp, Eric
    Sampson, John
    Friedman, Allan
    Friedman, Henry
    Ashley, David
    Bigner, Darell
    NEURO-ONCOLOGY, 2018, 20 : 9 - 9
  • [3] Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG).
    Desjardins, Annick
    Randazzo, Dina
    Chandramohan, Vidyalakshmi
    Peters, Katherine B.
    Johnson, Margaret O.
    Threatt, Stevie
    Bullock, Chevelle A.
    Herndon, James Emmett
    Healy, Patrick
    Lipp, Eric S.
    Sampson, John H.
    Friedman, Allan H.
    Friedman, Henry S.
    Ashley, David M.
    Bigner, Darell D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] DOSE FINDING AND DOSE EXPANSION TRIAL OF D2C7 IMMUNOTOXIN (D2C7-IT) ADMINISTERED INTRATUMORALLY VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMA (MG)
    Desjardins, Annick
    Randazzo, Dina
    Chandramohan, Vidya
    Peters, Katherine
    Johnson, Margaret
    Threatt, Stevie
    Bullock, Chevelle
    Jackman, Jenny
    Healy, Patrick
    Lipp, Eric
    Sampson, John
    Friedman, Allan
    Friedman, Henry
    Ashley, David
    Bigner, Darell
    NEURO-ONCOLOGY, 2019, 21 : 6 - 6
  • [5] DOSE ESCALATION TRIAL OF FC-ENGINEERED ANTI-CD40 MONOCLONAL ANTIBODY (2141-V11) ADMINISTERED INTRATUMORALLY WITH D2C7-IT VIA CONVECTION-ENHANCED DELIVERY (CED) FOR RECURRENT MALIGNANT GLIOMAS (RMGS)
    Desjardins, Annick
    Chandramohan, Vidya
    Landi, Daniel
    Peters, Katherine B.
    Johnson, Margaret
    Khasraw, Mustafa
    Low, Justin
    Threatt, Stevie
    Bullock, Chevelle
    Herndon, James E., II
    Lipp, Eric S.
    Sampson, John
    Friedman, Allan
    Friedman, Henry S.
    Ashley, David
    Knorr, David
    Ravetch, Jeffrey
    Bigner, Darell
    NEURO-ONCOLOGY, 2022, 24 : 65 - 65
  • [6] Final results of phase I/II studies of IL13-PE38QQR administered intratumorally (IT) and/or peritumorally (PT) via convection-enhanced delivery (CED) in patients undergoing tumor resection for recurrent malignant glioma.
    Prados, M
    Kunwar, S
    Lang, FF
    Ram, Z
    Westphal, M
    Barnett, G
    Sampson, JH
    Croteau, D
    Puri, RK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 115S - 115S
  • [7] A phase 1 trial of D2C7-it in combination with an Fc-engineered anti-CD40 monoclonal antibody (2141-V11) administered intratumorally via convectionenhanced delivery for adult patients with recurrent malignant glioma (MG).
    Desjardins, Annick
    Chandramohan, Vidyalakshmi
    Landi, Daniel B.
    Johnson, Margaret O.
    Khasraw, Mustafa
    Peters, Katherine B.
    Low, Justin
    Herndon, James Emmett
    Threatt, Stevie
    Bullock, Chevelle A.
    Lipp, Eric S.
    Sampson, John H.
    Friedman, Allan H.
    Friedman, Henry S.
    Ashley, David M.
    Knorr, David
    Bigner, Darell D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
    Souweidane, Mark M.
    Kramer, Kim
    Pandit-Taskar, Neeta
    Zhou, Zhiping
    Haque, Sofia
    Zanzonico, Pat
    Carrasquillo, Jorge A.
    Lyashchenko, Serge K.
    Thakur, Sunitha B.
    Donzelli, Maria
    Turner, Ryan S.
    Lewis, Jason S.
    Cheung, Nai-Kong V.
    Larson, Steven M.
    Dunkel, Ira J.
    LANCET ONCOLOGY, 2018, 19 (08): : 1040 - 1050
  • [9] Convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma multiforme: A phase 1/2 study
    Goldbrunner, R
    Tanner, P
    Holtmannspoetter, M
    Poepperl, G
    Rachinger, W
    Kreth, F
    Tonn, J
    NEURO-ONCOLOGY, 2005, 7 (03) : 310 - 311
  • [10] A phase I study of convection-enhanced delivery of nanoliposomal irinotecan using real-time imaging in patients with recurrent high grade glioma.
    Butowski, Nicholas A.
    Han, Seunggu
    Taylor, Jennie Webster
    Aghi, Manish K.
    Prados, Michael
    Chang, Susan Marina
    Clarke, Jennifer Leigh
    Bankiewicz, Krys
    Drummond, Daryl C.
    Fitzgerald, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12